Alternatively, AML cells with a lower FLT3 allelic ratio exhibit a reduced inhibitory effects of FLT3 inhibitors mediated by increased activation of the FLT3 wild-type31. This evidence concerns the gene FLT3 and acute myeloid leukemia.